Tag: ai-powered clinical trial site feasibility market analysis

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

#Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Size And Revenue Forecast Through 2030

The market for deep learning in drug discovery and diagnostics has seen exponential expansion in recent years. Projections indicate it will increase from $10.58 billion in 2025 to $13.61 billion in 2026, achieving a compound annual growth rate (CAGR) of 28.7%. The historic period’s growth can be explained by the greater accessibility of extensive biomedical datasets, enhanced computational capabilities for training models, broader integration of AI into pharmaceutical research and development, an increased need for quicker drug discovery timelines, and the initial effectiveness of deep learning-based diagnostic systems.

The deep learning market within drug discovery and diagnostics is projected to experience robust expansion during the coming years. By 2030, its value is anticipated to reach $36.96 billion, reflecting a compound annual growth rate (CAGR) of 28.4%. This upward trajectory in the forecast period is driven by factors such as heightened investments in AI-powered healthcare solutions, a growing demand for precision medicine, broader incorporation of artificial intelligence into clinical workflows, increased utilization of real-world evidence data, and rising regulatory endorsement of AI-assisted diagnostic tools. Significant trends shaping this period encompass the widespread application of deep neural networks for drug screening, the growing reliance on AI-driven predictive modeling in diagnostics, the expanding incorporation of multi-omics data analysis, the proliferation of automated clinical decision support systems, and a stronger emphasis on personalized medicine platforms.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28137&type=smp

Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Opportunity Drivers: What Is Creating New Revenue Potential?

The increasing need for customized treatments is set to propel advancements in the market for deep learning in drug discovery and diagnostics. Personalized medicine adapts medical care to individual genetic, environmental, and lifestyle profiles, aiming to boost effectiveness while reducing negative effects. This rising demand is fueled by progress in genomics and data analysis, which allow for more targeted and accurate therapies tailored to each patient’s distinct characteristics. In this context, deep learning improves personalized medicine by processing intricate biological data to highlight specific biomarkers and more reliably forecast how patients will respond to treatments. For example, in February 2024, the Personalized Medicine Coalition, a nonprofit organization based in the United States, reported that the FDA greenlit 16 new personalized therapies for individuals with rare conditions in 2023, up from just six in 2022. Hence, the growing preference for personalized medicine is driving the expansion of the deep learning in drug discovery and diagnostics market.

Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Segment Landscape: Which Areas Lead Market Development?

The computer-aided drug discovery market covered in this report is segmented –

1) By Type: Structure Based Drug Design, Ligand-Based Drug Design, Sequence-Based Approaches

2) By Therapeutic Area: Oncology, Neurology, Cardiovascular Disease, Respiratory Disease, Diabetes, Other Therapeutic Areas

3) By End User: Pharmaceutical Companies, Biotechnology Companies, Research Laboratories

Subsegments:

1) By Structure Based Drug Design: X-ray Crystallography, Nuclear Magnetic Resonance (NMR) Spectroscopy, Molecular Docking Studies, Virtual Screening

2) By Ligand-Based Drug Design: Quantitative Structure-Activity Relationship (QSAR) Models, Pharmacophore Modeling, Ligand Similarity Searching, Fragment-Based Drug Design

3) By Sequence-Based Approaches: Protein Structure Prediction, Homology Modeling, Bioinformatics for Drug Target Identification, Genomic Data Analysis for Drug Discovery

Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Innovation Trends Driving Future Development

Major players in the deep learning drug discovery and diagnostics market are integrating cutting-edge technologies such as generative artificial intelligence (AI) and machine-learning (ML)-powered automation platforms to boost efficiency, cut research and development (R&D) expenses, and expedite the identification of early-stage treatments. These generative AI and ML-driven automation platforms are computational systems that analyze chemical and biological datasets to generate new drug candidates in silico, forecast molecular properties, and streamline the synthesis and testing of compounds via robotic systems, thus decreasing dependence on conventional high-throughput screening methods. A case in point is July 2024, when Exscientia, a UK-based AI-focused drug design firm, unveiled its AWS-hosted AI/ML platform. This system pairs a “DesignStudio” for AI-powered molecule creation with an “AutomationStudio” for robotic lab synthesis and evaluation. Functioning within a closed “design–make–test–learn” cycle, experimental results continuously enhance the AI models, markedly hastening discovery, expanding scalability, and facilitating more precise and cost-effective development of innovative therapies.

Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Industry Leaders And Market Competition

Major companies operating in the computer-aided drug discovery market are Dassault Systèmes SE, PerkinElmer Inc., Roivant Sciences Ltd., Certara Inc., Schrödinger Inc., XtalPi Inc., Dotmatics Limited, Simulations Plus Inc., ChemAxon Ltd., Exscientia Ltd., Insilico Medicine Inc., Collaborative Drug Discovery Inc., OpenEye Scientific Software Inc., Nimbus Therapeutics LLC, Atomwise Inc., GNS Healthcare Inc., BenevolentAI Limited, EpiVax Inc., Numerate Inc., Cloud Pharmaceuticals Inc., Aris Pharmaceuticals Inc., Cyclica Inc., BioSolveIT GmbH, Chemical Computing Group ULC, InSilicoTrials Technologies S.p.A

Access The Complete Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Report:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-powered-clinical-trial-site-feasibility-global-market-report

Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Geographic Distribution And Regional Opportunities

North America was the largest region in the computer-aided drug discovery (CADD) market in 2025. The regions covered in the computer-aided drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=28934&type=smp

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Revenue Outlook: What CAGR Is Expected Through 2030?

The market for artificial intelligence powered tools used in assessing clinical trial site feasibility has experienced remarkable expansion. Projections indicate a significant increase from its 2025 valuation of 1.53 billion dollars to 1.89 billion dollars by 2026, reflecting a compound annual growth rate of 23.6%. This trajectory of growth throughout the historical period is fueled by several key factors: the escalating complexity inherent in clinical trial designs, mounting cost imperatives associated with drug development schedules, a heightened dependence on data to inform trial planning strategies, the proliferation of international multi site clinical trials, and the early integration of predictive analytics into the feasibility assessment process.

The market for artificial intelligence (AI) solutions designed to assess clinical trial site feasibility is projected to experience substantial expansion in the coming years, reaching an estimated $4.38 billion by 2030, driven by a compound annual growth rate of 23.3%. This accelerated growth trajectory is anticipated due to several key factors, including the increasing implementation of decentralized clinical trial models, a heightened need for expedited site activation processes, a greater reliance on real-world evidence for making informed feasibility determinations, the proliferation of AI-powered trial planning instruments, and a strengthened commitment to minimizing trial-related risks. Within this forecast period, significant trends are expected to shape the landscape, such as the wider embrace of AI-driven methodologies for site selection, a surge in the utilization of predictive analytics for patient recruitment, the deeper incorporation of real-world data into feasibility evaluations, the advancement and adoption of cloud-based feasibility platforms, and a more pronounced concentration on forecasting trial performance metrics.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28137&type=smp

#Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Demand Drivers Creating New Revenue Opportunities

The surge in clinical trials is anticipated to be a primary catalyst for the advancement of the artificial intelligence (AI)-enabled clinical trial site feasibility sector. Clinical trials, which are research investigations undertaken worldwide to assess the safety and effectiveness of novel medical interventions, pharmaceuticals, and equipment, are experiencing an uptick. This expansion in clinical trial activity stems from amplified funding directed towards biomedical research and development, as governmental and commercial entities alike acknowledge the crucial necessity of novel therapeutic approaches to combat escalating health concerns. The proliferation of clinical trials consequently fuels a demand for AI-driven solutions designed for site feasibility, empowering research entities to pinpoint ideal study locations, evaluate the proficiency of these sites, and forecast the likelihood of participant enrollment for their trials. To illustrate, as of April 2025, the clinicaltrials.gov platform listed a total of 404,637 interventional clinical trials, according to data from the Multidisciplinary Digital Publishing Institute, a Swiss-based open-access scientific journal publisher. Consequently, this burgeoning landscape of clinical trials is directly contributing to the expansion of the AI-powered clinical trial site feasibility market.

Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Categorization By Product Type And Application

The artificial intelligence (AI)-powered clinical trial site feasibility market covered in this report is segmented –

1) By Component: Software, Services

2) By Deployment Mode: Cloud-Based, On-Premises

3) By Application: Site Selection, Patient Recruitment, Protocol Design, Performance Analytics, Other Applications

4) By End-User: Pharmaceutical Companies, Contract Research Organizations, Academic Research Institutes, Hospitals, Other End-Users

Subsegments:

1) By Software: Predictive Analytics Software, Machine Learning (ML) Platforms, Natural Language Processing (NLP) Tools, Data Visualization Software, Clinical Trial Management System (CTMS) Integration Software, Real-World Data (RWD) Analytics Software, Risk-Based Monitoring (RBM) Software

2) By Services: Feasibility Assessment Services, Site Selection Services, Patient Recruitment Support Services, Data Management And Analytics Services, Protocol Optimization Services, Regulatory Compliance Support Services, Consulting And Advisory Services

Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Trends Driving Strategic Industry Expansion

Leading participants in the AI-driven clinical trial site feasibility sector are prioritizing the creation of sophisticated tools, notably an AI-powered platform for feasibility and recruitment, aimed at refining site selection processes and elevating the general operational effectiveness of clinical studies. This type of platform utilizes artificial intelligence and machine learning to meticulously analyze trial protocols and site-specific data, thereby pinpointing the most suitable clinical locations and bolstering patient recruitment by intelligently connecting suitable individuals, ultimately expediting trial durations and improving study outcomes. As an illustration, in June of 2023, ObjectiveHealth, a technology and research solutions provider headquartered in the United States, introduced ObjectiveScreen, an AI-centric platform engineered to boost clinical trial performance. This system achieves this by improving patient identification, pre-qualification, and retention through seamless integration with electronic health records and the application of AI and machine learning techniques, thereby enabling clinical research sites to directly access patient information, assess health risks, and identify the most appropriate participants, leading to faster enrollment and better trial results.

Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Company Landscape And Strategic Competition

Major companies operating in the artificial intelligence (AI)-powered clinical trial site feasibility market are Oracle Corporation, Thermo Fisher Scientific Inc., NVIDIA Corporation, IQVIA Holdings Inc., Labcorp Holdings Inc., Dassault Systèmes SE, Parexel International Corporation, ZS Associates Inc., Veeva Systems Inc., Verily Life Sciences LLC, Signant Health Holding Corp., Saama Technologies LLC, Elligo Health Research Inc., ConcertAI Inc., Medable Inc., Science 37 Inc., Castor EDC Inc., Unlearn.AI Inc., Antidote Technologies Inc., Deep 6 AI

Access The Complete Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Report:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-powered-clinical-trial-site-feasibility-global-market-report

Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Regional Outlook: Where Are The Largest Opportunities Located?

North Americawas the largest region in the artificial intelligence (AI)-powered clinical trial site feasibility market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-powered clinical trial site feasibility market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Growth In Market Size Of The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market During 2026–2030?

The artificial intelligence (AI)-powered clinical trial site feasibility market size has experienced substantial growth in recent years. It is forecast to expand from $1.53 billion in 2025 to $1.89 billion in 2026, achieving a compound annual growth rate (CAGR) of 23.6%. This historical market expansion can be ascribed to increasing complexity of clinical trial designs, rising cost pressures on drug development timelines, growing reliance on data-driven trial planning, expansion of global multi-site clinical trials, and early adoption of predictive analytics in trial feasibility.

The artificial intelligence (AI)-powered clinical trial site feasibility market size is projected to experience substantial growth in the coming years. This sector is expected to reach $4.38 billion by 2030, demonstrating a robust compound annual growth rate (CAGR) of 23.3%.

This growth during the forecast period is primarily driven by the increasing adoption of decentralized clinical trials, a rising need for faster site activation, the expanded utilization of real-world evidence in feasibility decisions, the proliferation of AI-enabled trial planning platforms, and a greater emphasis on mitigating trial risks. Concurrently, major trends anticipated include the growing embrace of AI-driven site selection models, a surge in the use of predictive patient recruitment analytics, deeper integration of real-world data into feasibility assessments, the expansion of cloud-based feasibility platforms, and an enhanced focus on forecasting trial performance.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28137&type=smp

What Are The Main Drivers Accelerating The Growth Of The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market?

The anticipated expansion of clinical trials is projected to fuel the advancement of the artificial intelligence (AI)-powered clinical trial site feasibility market. Clinical trials encompass global research investigations aimed at evaluating the safety and effectiveness of novel medical treatments, pharmaceuticals, and devices. This increase in clinical trials primarily stems from heightened investments in biomedical research and development, as both public and private entities acknowledge the vital necessity of groundbreaking treatments to confront evolving healthcare issues. The proliferation of clinical trials consequently boosts the demand for AI-powered site feasibility tools, given that research organizations require effective systems to pinpoint ideal locations, evaluate site competencies, and forecast participant enrollment success for their studies. Illustratively, in April 2025, data from the Multidisciplinary Digital Publishing Institute, a Swiss publisher of open-access scientific journals, indicated that the total number of clinical trials available on the clinicaltrials.gov webpage reached 404,637. Consequently, the expansion of clinical trials is a key driver for the advancement of the artificial intelligence (AI)-powered clinical trial site feasibility market.

How Is The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Distributed Across Key Segments?

The artificial intelligence (AI)-powered clinical trial site feasibility market covered in this report is segmented –

1) By Component: Software, Services

2) By Deployment Mode: Cloud-Based, On-Premises

3) By Application: Site Selection, Patient Recruitment, Protocol Design, Performance Analytics, Other Applications

4) By End-User: Pharmaceutical Companies, Contract Research Organizations, Academic Research Institutes, Hospitals, Other End-Users

Subsegments:

1) By Software: Predictive Analytics Software, Machine Learning (ML) Platforms, Natural Language Processing (NLP) Tools, Data Visualization Software, Clinical Trial Management System (CTMS) Integration Software, Real-World Data (RWD) Analytics Software, Risk-Based Monitoring (RBM) Software

2) By Services: Feasibility Assessment Services, Site Selection Services, Patient Recruitment Support Services, Data Management And Analytics Services, Protocol Optimization Services, Regulatory Compliance Support Services, Consulting And Advisory Services

Which Trends Are Affecting The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Framework?

Leading companies operating in the artificial intelligence-powered clinical trial site feasibility market are focusing on developing advanced solutions, such as an artificial intelligence-powered feasibility and recruitment platform, to optimize site selection and improve overall operational efficiency in clinical trials. This specific platform functions as a software tool that leverages AI and machine learning to assess trial protocols and site data, aiming to identify optimal clinical sites and enhance patient recruitment by efficiently matching eligible participants to accelerate trial timelines and boost study success. For instance, in June 2023, ObjectiveHealth, a US-based integrated research and technology platform company, launched ObjectiveScreen. This artificial intelligence-powered feasibility and recruitment platform is designed to optimize clinical trial performance through enhanced patient identification, prequalification, and retention, achieved via real-time integration with electronic health records (EHRs) and the application of AI and machine learning algorithms. The platform empowers clinical trial sites to connect directly with patient data, stratify health risks, and pinpoint the most qualified candidates, ultimately accelerating enrollment and improving trial outcomes.

Which Industry Players Are Present In The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market?

Major companies operating in the artificial intelligence (AI)-powered clinical trial site feasibility market are Oracle Corporation, Thermo Fisher Scientific Inc., NVIDIA Corporation, IQVIA Holdings Inc., Labcorp Holdings Inc., Dassault Systèmes SE, Parexel International Corporation, ZS Associates Inc., Veeva Systems Inc., Verily Life Sciences LLC, Signant Health Holding Corp., Saama Technologies LLC, Elligo Health Research Inc., ConcertAI Inc., Medable Inc., Science 37 Inc., Castor EDC Inc., Unlearn.AI Inc., Antidote Technologies Inc., Deep 6 AI

Access The Complete Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Report:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-powered-clinical-trial-site-feasibility-global-market-report

Which Geographic Region Represents The Largest Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Share?

North America was the largest region in the artificial intelligence (AI)-powered clinical trial site feasibility market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-powered clinical trial site feasibility market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=28137&type=smp

Browse Through More Reports Similar to the Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market 2026, By The Business Research Company

Ai Based Clinical Trial Solution Providers Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/ai-based-clinical-trial-solution-providers-global-market-report

Ai In Clinical Trials Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/ai-in-clinical-trials-global-market-report

Virtual Clinical Trials Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/virtual-clinical-trials-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Expected To Change From 2026 To 2030?

The artificial intelligence (AI)-powered clinical trial site feasibility market has experienced considerable growth in recent years. Projections indicate it will rise from $1.53 billion in 2025 to $1.89 billion in 2026, achieving a compound annual growth rate (CAGR) of 23.6%. This historical expansion is attributable to factors such as the increasing complexity of clinical trial designs, rising cost pressures on drug development timelines, a growing reliance on data-driven trial planning, the expansion of global multi-site clinical trials, and the early adoption of predictive analytics in trial feasibility.

The market for artificial intelligence (AI)-powered clinical trial site feasibility is projected to experience rapid expansion over the coming years. This market is anticipated to reach a valuation of $4.38 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 23.3%. Factors contributing to this anticipated growth include the wider acceptance of decentralized clinical trials, a greater need for expedited site activation, the expanding application of real-world evidence in making feasibility determinations, the proliferation of AI-enabled platforms for trial planning, and a heightened focus on reducing trial risks. Key trends expected during the forecast timeframe encompass the increasing implementation of AI-powered models for site selection, the growing utilization of predictive analytics for patient recruitment, the deeper incorporation of real-world data into feasibility evaluations, the expansion of cloud-hosted feasibility platforms, and an elevated emphasis on forecasting trial performance.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-powered-clinical-trial-site-feasibility-global-market-report

What Key Factors Are Affecting The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Demand?

The increasing volume of clinical trials is anticipated to drive the expansion of the artificial intelligence (AI)-powered clinical trial site feasibility market moving ahead. These trials represent global clinical research investigations designed to evaluate the safety and effectiveness of novel medical treatments, drugs, and devices. The uptick in clinical trials is largely propelled by greater investment in biomedical research and development, as both governmental and private entities acknowledge the crucial need for innovative solutions to tackle evolving healthcare challenges. Such an expansion generates demand for AI-powered site feasibility tools, given that research organizations require efficient systems to pinpoint optimal study locations, evaluate site proficiencies, and forecast enrollment success rates. For example, in April 2025, the Multidisciplinary Digital Publishing Institute, a Switzerland-based publisher of open-access scientific journals, reported 404,637 interventional clinical trials on the clinicaltrials.gov webpage. Consequently, the surge in clinical trials is a primary impetus for the growth of the artificial intelligence (AI)-powered clinical trial site feasibility market.

How Is The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Categorized Across Its Segment Groups?

The artificial intelligence (AI)-powered clinical trial site feasibility market covered in this report is segmented –

1) By Component: Software, Services

2) By Deployment Mode: Cloud-Based, On-Premises

3) By Application: Site Selection, Patient Recruitment, Protocol Design, Performance Analytics, Other Applications

4) By End-User: Pharmaceutical Companies, Contract Research Organizations, Academic Research Institutes, Hospitals, Other End-Users

Subsegments:

1) By Software: Predictive Analytics Software, Machine Learning (ML) Platforms, Natural Language Processing (NLP) Tools, Data Visualization Software, Clinical Trial Management System (CTMS) Integration Software, Real-World Data (RWD) Analytics Software, Risk-Based Monitoring (RBM) Software

2) By Services: Feasibility Assessment Services, Site Selection Services, Patient Recruitment Support Services, Data Management And Analytics Services, Protocol Optimization Services, Regulatory Compliance Support Services, Consulting And Advisory Services

What Trends Are Influencing Changes In The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market?

Major companies operating in the artificial intelligence-powered clinical trial site feasibility market are concentrating on developing advanced solutions, such as an artificial intelligence-powered feasibility and recruitment platform, to refine site selection and enhance overall operational efficiency in clinical trials. This type of platform is a software solution that leverages AI and machine learning to evaluate trial protocols and site data, aiming to identify optimal clinical sites and improve patient recruitment by efficiently matching eligible participants to accelerate trial timelines and boost study success. For instance, in June 2023, ObjectiveHealth, a US-based integrated research and technology platform company, introduced ObjectiveScreen. This artificial intelligence-powered feasibility and recruitment platform was designed to optimize clinical trial performance by enhancing patient identification, prequalification, and retention through real-time integration with electronic health records (EHRs) and the utilization of AI and machine learning algorithms. The platform allows clinical trial sites to directly connect with patient data, stratify health risks, and identify the most qualified candidates to accelerate enrollment and improve trial outcomes.

Which Firms Are Influencing Competition In The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market?

Major companies operating in the artificial intelligence (AI)-powered clinical trial site feasibility market are Oracle Corporation, Thermo Fisher Scientific Inc., NVIDIA Corporation, IQVIA Holdings Inc., Labcorp Holdings Inc., Dassault Systèmes SE, Parexel International Corporation, ZS Associates Inc., Veeva Systems Inc., Verily Life Sciences LLC, Signant Health Holding Corp., Saama Technologies LLC, Elligo Health Research Inc., ConcertAI Inc., Medable Inc., Science 37 Inc., Castor EDC Inc., Unlearn.AI Inc., Antidote Technologies Inc., Deep 6 AI

Get The Full Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Report:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-powered-clinical-trial-site-feasibility-global-market-report

Which Region Is The Leading Market For The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market?

North America was the largest region in the artificial intelligence (AI)-powered clinical trial site feasibility market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-powered clinical trial site feasibility market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-powered-clinical-trial-site-feasibility-global-market-report

Browse Through More Reports Similar to the Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market 2026, By The Business Research Company

Virtual Clinical Trials Market Report 2026

https://www.thebusinessresearchcompany.com/report/virtual-clinical-trials-global-market-report

Ai Based Clinical Trial Solution Providers Market Report 2026

https://www.thebusinessresearchcompany.com/report/ai-based-clinical-trial-solution-providers-global-market-report

Ai In Clinical Trials Market Report 2026

https://www.thebusinessresearchcompany.com/report/ai-in-clinical-trials-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Over The 2026–2030 Period?

The market size for artificial intelligence (AI)-powered clinical trial site feasibility has experienced rapid expansion over recent years. This market is projected to expand from $1.53 billion in 2025 to $1.89 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 23.6%. Historical growth in this sector is largely due to factors such as the increasing intricacy of clinical trial designs, heightened cost pressures affecting drug development timelines, a greater dependence on data-driven approaches for trial planning, the proliferation of global multi-site clinical trials, and the initial incorporation of predictive analytics into trial feasibility assessments.

The market for artificial intelligence (AI)-powered solutions in clinical trial site feasibility is projected to experience substantial expansion in the coming years. This market is anticipated to reach $4.38 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 23.3%. Factors contributing to this growth during the forecast period include the greater embrace of decentralized clinical trials, an escalating need for expedited site activation, the expanding utilization of real-world evidence for feasibility determinations, the proliferation of AI-enabled platforms for trial planning, and a heightened focus on mitigating trial risks. Key trends anticipated within the forecast timeframe encompass the wider adoption of AI-driven models for site selection, the increasing application of predictive analytics for patient recruitment, the deeper integration of real-world data into feasibility evaluations, the growth of cloud-based platforms for feasibility, and an intensified concentration on forecasting trial performance.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28137&type=smp

What Drivers Are Expected To Influence The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market During The Forecast Period?

The anticipated expansion of clinical trials is set to fuel the growth of the artificial intelligence (AI)-powered clinical trial site feasibility market. Clinical trials are defined as global research investigations conducted to evaluate the safety and effectiveness of novel medical treatments, drugs, and devices. The increase in these trials is largely propelled by heightened investment in biomedical research and development, as both governmental and private entities recognize the crucial need for innovative solutions to address evolving healthcare challenges. This expansion consequently generates a need for AI-powered site feasibility tools, enabling research organizations to efficiently pinpoint optimal locations, assess site capabilities, and project enrollment success rates for their studies. For instance, data from the Multidisciplinary Digital Publishing Institute, a Switzerland-based publisher of open-access scientific journals, indicated that in April 2025, there were 404,637 interventional clinical trials accessible on the clinicaltrials.gov webpage. Thus, the escalating number of clinical trials is undeniably propelling the artificial intelligence (AI)-powered clinical trial site feasibility market forward.

How Is The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Segmented Across Key Categories?

The artificial intelligence (AI)-powered clinical trial site feasibility market covered in this report is segmented –

1) By Component: Software, Services

2) By Deployment Mode: Cloud-Based, On-Premises

3) By Application: Site Selection, Patient Recruitment, Protocol Design, Performance Analytics, Other Applications

4) By End-User: Pharmaceutical Companies, Contract Research Organizations, Academic Research Institutes, Hospitals, Other End-Users

Subsegments:

1) By Software: Predictive Analytics Software, Machine Learning (ML) Platforms, Natural Language Processing (NLP) Tools, Data Visualization Software, Clinical Trial Management System (CTMS) Integration Software, Real-World Data (RWD) Analytics Software, Risk-Based Monitoring (RBM) Software

2) By Services: Feasibility Assessment Services, Site Selection Services, Patient Recruitment Support Services, Data Management And Analytics Services, Protocol Optimization Services, Regulatory Compliance Support Services, Consulting And Advisory Services

Which Trends Are Influencing The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market?

Leading companies in the artificial intelligence-powered clinical trial site feasibility market are concentrating on creating sophisticated solutions, like an artificial intelligence-powered feasibility and recruitment platform, to enhance site selection and boost overall operational efficiency in clinical trials. Such a platform is a software solution that utilizes AI and machine learning to evaluate trial protocols and site information, pinpointing the most suitable clinical sites and improving patient recruitment by effectively connecting eligible participants, thereby expediting trial timelines and increasing study success. For example, in June 2023, ObjectiveHealth, a US-based integrated research and technology platform company, introduced ObjectiveScreen, an artificial intelligence-powered feasibility and recruitment platform. This platform aims to optimize clinical trial performance by improving patient identification, prequalification, and retention through its real-time integration with electronic health records (EHRs) and its application of AI and machine learning algorithms. It empowers clinical trial sites to directly access patient data, categorize health risks, and identify the most appropriate candidates to accelerate enrollment and achieve better trial outcomes.

Who Are The Dominant Players Shaping The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Landscape?

Major companies operating in the artificial intelligence (AI)-powered clinical trial site feasibility market are Oracle Corporation, Thermo Fisher Scientific Inc., NVIDIA Corporation, IQVIA Holdings Inc., Labcorp Holdings Inc., Dassault Systèmes SE, Parexel International Corporation, ZS Associates Inc., Veeva Systems Inc., Verily Life Sciences LLC, Signant Health Holding Corp., Saama Technologies LLC, Elligo Health Research Inc., ConcertAI Inc., Medable Inc., Science 37 Inc., Castor EDC Inc., Unlearn.AI Inc., Antidote Technologies Inc., Deep 6 AI

Read the full artificial intelligence (ai)-powered clinical trial site feasibility market report here:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-powered-clinical-trial-site-feasibility-global-market-report

Which Region Is Forecast To Lead The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market In Terms Of Market Size?

North America was the largest region in the artificial intelligence (AI)-powered clinical trial site feasibility market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-powered clinical trial site feasibility market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28137&type=smp

Browse Through More Reports Similar to the Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market 2026, By The Business Research Company

Ai Based Clinical Trial Solution Providers Global Market Report

https://www.thebusinessresearchcompany.com/report/ai-based-clinical-trial-solution-providers-global-market-report

Ai In Clinical Trials Global Market Report

https://www.thebusinessresearchcompany.com/report/ai-in-clinical-trials-global-market-report

Virtual Clinical Trials Global Market Report

https://www.thebusinessresearchcompany.com/report/virtual-clinical-trials-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Over The 2026–2030 Period?

The market size for artificial intelligence (AI)-powered clinical trial site feasibility has experienced rapid expansion over recent years. This market is projected to expand from $1.53 billion in 2025 to $1.89 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 23.6%. Historical growth in this sector is largely due to factors such as the increasing intricacy of clinical trial designs, heightened cost pressures affecting drug development timelines, a greater dependence on data-driven approaches for trial planning, the proliferation of global multi-site clinical trials, and the initial incorporation of predictive analytics into trial feasibility assessments.

The market for artificial intelligence (AI)-powered solutions in clinical trial site feasibility is projected to experience substantial expansion in the coming years. This market is anticipated to reach $4.38 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 23.3%. Factors contributing to this growth during the forecast period include the greater embrace of decentralized clinical trials, an escalating need for expedited site activation, the expanding utilization of real-world evidence for feasibility determinations, the proliferation of AI-enabled platforms for trial planning, and a heightened focus on mitigating trial risks. Key trends anticipated within the forecast timeframe encompass the wider adoption of AI-driven models for site selection, the increasing application of predictive analytics for patient recruitment, the deeper integration of real-world data into feasibility evaluations, the growth of cloud-based platforms for feasibility, and an intensified concentration on forecasting trial performance.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28137&type=smp

What Drivers Are Expected To Influence The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market During The Forecast Period?

The anticipated expansion of clinical trials is set to fuel the growth of the artificial intelligence (AI)-powered clinical trial site feasibility market. Clinical trials are defined as global research investigations conducted to evaluate the safety and effectiveness of novel medical treatments, drugs, and devices. The increase in these trials is largely propelled by heightened investment in biomedical research and development, as both governmental and private entities recognize the crucial need for innovative solutions to address evolving healthcare challenges. This expansion consequently generates a need for AI-powered site feasibility tools, enabling research organizations to efficiently pinpoint optimal locations, assess site capabilities, and project enrollment success rates for their studies. For instance, data from the Multidisciplinary Digital Publishing Institute, a Switzerland-based publisher of open-access scientific journals, indicated that in April 2025, there were 404,637 interventional clinical trials accessible on the clinicaltrials.gov webpage. Thus, the escalating number of clinical trials is undeniably propelling the artificial intelligence (AI)-powered clinical trial site feasibility market forward.

How Is The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Segmented Across Key Categories?

The artificial intelligence (AI)-powered clinical trial site feasibility market covered in this report is segmented –

1) By Component: Software, Services

2) By Deployment Mode: Cloud-Based, On-Premises

3) By Application: Site Selection, Patient Recruitment, Protocol Design, Performance Analytics, Other Applications

4) By End-User: Pharmaceutical Companies, Contract Research Organizations, Academic Research Institutes, Hospitals, Other End-Users

Subsegments:

1) By Software: Predictive Analytics Software, Machine Learning (ML) Platforms, Natural Language Processing (NLP) Tools, Data Visualization Software, Clinical Trial Management System (CTMS) Integration Software, Real-World Data (RWD) Analytics Software, Risk-Based Monitoring (RBM) Software

2) By Services: Feasibility Assessment Services, Site Selection Services, Patient Recruitment Support Services, Data Management And Analytics Services, Protocol Optimization Services, Regulatory Compliance Support Services, Consulting And Advisory Services

Which Trends Are Influencing The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market?

Leading companies in the artificial intelligence-powered clinical trial site feasibility market are concentrating on creating sophisticated solutions, like an artificial intelligence-powered feasibility and recruitment platform, to enhance site selection and boost overall operational efficiency in clinical trials. Such a platform is a software solution that utilizes AI and machine learning to evaluate trial protocols and site information, pinpointing the most suitable clinical sites and improving patient recruitment by effectively connecting eligible participants, thereby expediting trial timelines and increasing study success. For example, in June 2023, ObjectiveHealth, a US-based integrated research and technology platform company, introduced ObjectiveScreen, an artificial intelligence-powered feasibility and recruitment platform. This platform aims to optimize clinical trial performance by improving patient identification, prequalification, and retention through its real-time integration with electronic health records (EHRs) and its application of AI and machine learning algorithms. It empowers clinical trial sites to directly access patient data, categorize health risks, and identify the most appropriate candidates to accelerate enrollment and achieve better trial outcomes.

Who Are The Dominant Players Shaping The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Landscape?

Major companies operating in the artificial intelligence (AI)-powered clinical trial site feasibility market are Oracle Corporation, Thermo Fisher Scientific Inc., NVIDIA Corporation, IQVIA Holdings Inc., Labcorp Holdings Inc., Dassault Systèmes SE, Parexel International Corporation, ZS Associates Inc., Veeva Systems Inc., Verily Life Sciences LLC, Signant Health Holding Corp., Saama Technologies LLC, Elligo Health Research Inc., ConcertAI Inc., Medable Inc., Science 37 Inc., Castor EDC Inc., Unlearn.AI Inc., Antidote Technologies Inc., Deep 6 AI

Read the full artificial intelligence (ai)-powered clinical trial site feasibility market report here:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-powered-clinical-trial-site-feasibility-global-market-report

Which Region Is Forecast To Lead The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market In Terms Of Market Size?

North America was the largest region in the artificial intelligence (AI)-powered clinical trial site feasibility market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-powered clinical trial site feasibility market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28137&type=smp

Browse Through More Reports Similar to the Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market 2026, By The Business Research Company

Ai Based Clinical Trial Solution Providers Global Market Report

https://www.thebusinessresearchcompany.com/report/ai-based-clinical-trial-solution-providers-global-market-report

Ai In Clinical Trials Global Market Report

https://www.thebusinessresearchcompany.com/report/ai-in-clinical-trials-global-market-report

Virtual Clinical Trials Global Market Report

https://www.thebusinessresearchcompany.com/report/virtual-clinical-trials-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Over The 2026–2030 Period?

The market size for artificial intelligence (AI)-powered clinical trial site feasibility has experienced rapid expansion over recent years. This market is projected to expand from $1.53 billion in 2025 to $1.89 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 23.6%. Historical growth in this sector is largely due to factors such as the increasing intricacy of clinical trial designs, heightened cost pressures affecting drug development timelines, a greater dependence on data-driven approaches for trial planning, the proliferation of global multi-site clinical trials, and the initial incorporation of predictive analytics into trial feasibility assessments.

The market for artificial intelligence (AI)-powered solutions in clinical trial site feasibility is projected to experience substantial expansion in the coming years. This market is anticipated to reach $4.38 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 23.3%. Factors contributing to this growth during the forecast period include the greater embrace of decentralized clinical trials, an escalating need for expedited site activation, the expanding utilization of real-world evidence for feasibility determinations, the proliferation of AI-enabled platforms for trial planning, and a heightened focus on mitigating trial risks. Key trends anticipated within the forecast timeframe encompass the wider adoption of AI-driven models for site selection, the increasing application of predictive analytics for patient recruitment, the deeper integration of real-world data into feasibility evaluations, the growth of cloud-based platforms for feasibility, and an intensified concentration on forecasting trial performance.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28137&type=smp

What Drivers Are Expected To Influence The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market During The Forecast Period?

The anticipated expansion of clinical trials is set to fuel the growth of the artificial intelligence (AI)-powered clinical trial site feasibility market. Clinical trials are defined as global research investigations conducted to evaluate the safety and effectiveness of novel medical treatments, drugs, and devices. The increase in these trials is largely propelled by heightened investment in biomedical research and development, as both governmental and private entities recognize the crucial need for innovative solutions to address evolving healthcare challenges. This expansion consequently generates a need for AI-powered site feasibility tools, enabling research organizations to efficiently pinpoint optimal locations, assess site capabilities, and project enrollment success rates for their studies. For instance, data from the Multidisciplinary Digital Publishing Institute, a Switzerland-based publisher of open-access scientific journals, indicated that in April 2025, there were 404,637 interventional clinical trials accessible on the clinicaltrials.gov webpage. Thus, the escalating number of clinical trials is undeniably propelling the artificial intelligence (AI)-powered clinical trial site feasibility market forward.

How Is The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Segmented Across Key Categories?

The artificial intelligence (AI)-powered clinical trial site feasibility market covered in this report is segmented –

1) By Component: Software, Services

2) By Deployment Mode: Cloud-Based, On-Premises

3) By Application: Site Selection, Patient Recruitment, Protocol Design, Performance Analytics, Other Applications

4) By End-User: Pharmaceutical Companies, Contract Research Organizations, Academic Research Institutes, Hospitals, Other End-Users

Subsegments:

1) By Software: Predictive Analytics Software, Machine Learning (ML) Platforms, Natural Language Processing (NLP) Tools, Data Visualization Software, Clinical Trial Management System (CTMS) Integration Software, Real-World Data (RWD) Analytics Software, Risk-Based Monitoring (RBM) Software

2) By Services: Feasibility Assessment Services, Site Selection Services, Patient Recruitment Support Services, Data Management And Analytics Services, Protocol Optimization Services, Regulatory Compliance Support Services, Consulting And Advisory Services

Which Trends Are Influencing The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market?

Leading companies in the artificial intelligence-powered clinical trial site feasibility market are concentrating on creating sophisticated solutions, like an artificial intelligence-powered feasibility and recruitment platform, to enhance site selection and boost overall operational efficiency in clinical trials. Such a platform is a software solution that utilizes AI and machine learning to evaluate trial protocols and site information, pinpointing the most suitable clinical sites and improving patient recruitment by effectively connecting eligible participants, thereby expediting trial timelines and increasing study success. For example, in June 2023, ObjectiveHealth, a US-based integrated research and technology platform company, introduced ObjectiveScreen, an artificial intelligence-powered feasibility and recruitment platform. This platform aims to optimize clinical trial performance by improving patient identification, prequalification, and retention through its real-time integration with electronic health records (EHRs) and its application of AI and machine learning algorithms. It empowers clinical trial sites to directly access patient data, categorize health risks, and identify the most appropriate candidates to accelerate enrollment and achieve better trial outcomes.

Who Are The Dominant Players Shaping The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Landscape?

Major companies operating in the artificial intelligence (AI)-powered clinical trial site feasibility market are Oracle Corporation, Thermo Fisher Scientific Inc., NVIDIA Corporation, IQVIA Holdings Inc., Labcorp Holdings Inc., Dassault Systèmes SE, Parexel International Corporation, ZS Associates Inc., Veeva Systems Inc., Verily Life Sciences LLC, Signant Health Holding Corp., Saama Technologies LLC, Elligo Health Research Inc., ConcertAI Inc., Medable Inc., Science 37 Inc., Castor EDC Inc., Unlearn.AI Inc., Antidote Technologies Inc., Deep 6 AI

Read the full artificial intelligence (ai)-powered clinical trial site feasibility market report here:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-powered-clinical-trial-site-feasibility-global-market-report

Which Region Is Forecast To Lead The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market In Terms Of Market Size?

North America was the largest region in the artificial intelligence (AI)-powered clinical trial site feasibility market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-powered clinical trial site feasibility market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28137&type=smp

Browse Through More Reports Similar to the Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market 2026, By The Business Research Company

Ai Based Clinical Trial Solution Providers Global Market Report

https://www.thebusinessresearchcompany.com/report/ai-based-clinical-trial-solution-providers-global-market-report

Ai In Clinical Trials Global Market Report

https://www.thebusinessresearchcompany.com/report/ai-in-clinical-trials-global-market-report

Virtual Clinical Trials Global Market Report

https://www.thebusinessresearchcompany.com/report/virtual-clinical-trials-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model